Preserving European Antibiotics: The Need for Sustainable R&D FundingÂ
Antibiotic resistance is a global public health threat. Modern health systems rely on antibiotics to prevent and treat infections, and...
top of page
Newsroom
Check on PrIMAVeRa's latest news
Aug 13
PrIMAVeRa project publishes on contact network dynamics to prevent pathogen transmission in hospitals
Activities continue in the PrIMAVeRa project, with the latest result being the publication of a new manuscript titled “Using contact...
55
Jun 25
PrIMAVeRa project advances in combating AMR: key insights from year two progress review meeting
Divided into two rounds during June, Consortium partners presented year two progress to SAC.
38
May 15
PrIMAVeRa project partners present posters at ECCMID 2024
The team shared challenges & solutions for data-sharing & re-use, and expert consensus on priorities for vaccine/mAb R&D and implementation.
34
Mar 8
PrIMAVeRa participates in AMR Accelerator Cross-Project Meeting 2024
The Cross-Project Meeting gathered nearly 40 participants representing 9 IHI-funded projects from the AMR Accelerator, in Basel, Switzerland
114
Nov 24, 2023
PrIMAVeRa provides in-depth reports on current evidence base of burden of AMR in Europe
The PrIMAVeRa project proudly announces the simultaneous publication of four informative systematic reviews.
239
Nov 24, 2023
PrIMAVeRa 2nd annual meeting successfully held in hybrid format in Utrecht on 15-16 November 2023
The meeting enabled dynamic panel discussions covering the burden of AMR, and model development and data access.
190
Jun 19, 2023
PrIMAVeRa Project Appoints Scientific Advisory Committee
The PrIMAVeRa project announces the appointment of the Scientific Advisory Committee (SAC).
92
Nov 30, 2022
PrIMAVeRa 1st annual meeting successfully held in a hybrid event in Verona on 29-30 November 2022
PrIMAVeRa team gathered for the first project annual meeting with around 30 project partners joining in Verona (IT), and virtually.
106
Feb 3, 2022
PrIMAVeRa WP2 workshop, virtually held on 27-28 January 2022
The 2-day workshop included an overview of WP2, presentation and discussion of AMR case studies, the draft of AMR protocol, and more.
207
Dec 15, 2021
PrIMAVeRa kick-off meeting successfully marks the official project launch
The PrIMAVeRa consortium held its Kick-off Meeting on 25 November 2021 marking the official launch of this ambitious endeavor.
76
Nov 9, 2021
PrIMAVeRa, an ambitious project to demonstrate how vaccines can combat AMR
The IMI2 Joint Undertaking mobilises more than € 9 million to harnessing the power of big data and AI to steer the fight against AMR
67
bottom of page